Compare BIO & MOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | MOH |
|---|---|---|
| Founded | 1952 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 10.8B |
| IPO Year | 1994 | 2002 |
| Metric | BIO | MOH |
|---|---|---|
| Price | $361.29 | $207.22 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 19 |
| Target Price | ★ $335.00 | $219.53 |
| AVG Volume (30 Days) | 212.7K | ★ 784.5K |
| Earning Date | 11-04-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.61 | N/A |
| EPS | N/A | ★ 2.19 |
| Revenue | $2,583,200,000.00 | ★ $45,426,000,000.00 |
| Revenue This Year | N/A | $2.71 |
| Revenue Next Year | $2.13 | $6.45 |
| P/E Ratio | ★ N/A | $93.37 |
| Revenue Growth | 0.65 | ★ 11.75 |
| 52 Week Low | $236.73 | $121.06 |
| 52 Week High | $396.23 | $244.89 |
| Indicator | BIO | MOH |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 52.90 |
| Support Level | $350.29 | $183.78 |
| Resistance Level | $391.87 | $207.60 |
| Average True Range (ATR) | 11.53 | 9.93 |
| MACD | 1.14 | -0.80 |
| Stochastic Oscillator | 38.10 | 37.66 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.